MAPT Antibody - middle region

Artikelnummer: ASB-ARP48103_P050
Artikelname: MAPT Antibody - middle region
Artikelnummer: ASB-ARP48103_P050
Hersteller Artikelnummer: ARP48103_P050
Alternativnummer: ASB-ARP48103_P050-25UL,ASB-ARP48103_P050-100UL
Hersteller: Aviva
Wirt: Rabbit
Kategorie: Proteine/Peptide
Applikation: IHC, WB
Spezies Reaktivität: Human, Mouse, Porcine, Rat
Immunogen: The immunogen is a synthetic peptide directed towards the middle region of human MAPT
Alternative Synonym: TAU, MSTD, PPND, DDPAC, MAPTL, MTBT1, MTBT2, tau-40, FTDP-17, PPP1R103
MAPT is differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. The mutations in the gene have been associated with several neurodegenerative disorders such as Alzheimers disease, Picks disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy.This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimers disease, Picks disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy.
Klonalität: Polyclonal
Konzentration: 0.5 mg/ml
Molekulargewicht: 79 kDa
NCBI: 4137
UniProt: P10636-8
Formulierung: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
Sample Type:
A: Transgenic hTau P301L mouse cortex B: Tau-Ko mouse cortex C: WT mouse cortex Primary Antibody Dilution:
1:1000Secondary Antibody:
Anti-rabbit-biotin / Avidin-HRP Secondary Antibody Dilution:
1:1000 /1:2000 Color/Signal Descriptions:
Dark grey: MAPT Gene Name:
MAPTSubmitted by:
Max Holzer, Paul Flechsig Institut of Brain Research, University of Leipzig
WB Suggested Anti-MAPT Antibody Titration: 0.2-1 ug/ml
Positive Control: HepG2 cell lysate
25 ug of the indicated Human whole cell extracts was loaded onto a 12% SDS-PAGE gel. 3 ug/mL of the antibody was used in this experiment. The peptide sequence is present in a 45 kDa isoform. The protein may be modified by acetylation, glycosylation, and phosphorylation.
Researcher: Max Holzer, Paul Flechsig Institut of Brain Research, University of Leipzig
Application: Western blotting
Species + Tissue/Cell type:
Lane 1: 10ug E.Coli: expressed human Tau-C
Lane 2: 10ug E.Coli: expressed human Tau-E
Lane 3: 10ug E.Coli: expressed human Tau-F
Lane 4: 10ug E.Coli: expressed human Tau-B
Lane 5: 10ug E.Coli: expressed human Fetal-Tau
Lane 6: 10ug E.Coli: expressed human Tau-D
Primary antibody dilution: 1:1000
Secondary antibody: Donkey anti-rabbit-HRP
Secondary antibody dilution: 1:10,000
MAPT antibody - middle region (ARP48103_P050) in Human HepG2 using Western Blot